Evidence map›Paper›PMID 22558323›Full record

ArticlePloS one2012

Consent for use of clinical leftover biosample: a survey among Chinese patients and the general public.

Yi Ma, HuiLi Dai, LiMin Wang, LiJun Zhu, HanBing Zou, XianMing Kong

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Trust and Support for Cancer Research Biobanks: Insights from Cancer Patients in Poland.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Public Attitudes toward Biobanking of Human Biological Material for Research Purposes: A Literature Review.International journal of environmental research and public health · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. Knowledge and Beliefs About Biospecimen Research Among Chinese Older Women in Chicago's Chinatown.The journals of gerontology. Series A, Biological sciences and medical sciences · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The MICHR Genomic DNA BioLibrary: An Empirical Study of the Ethics of Biorepository Development.Journal of empirical research on human research ethics : JERHRE · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yi MaDepartment of Biobank, Renji Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
HuiLi Dai
LiMin Wang
LiJun Zhu
HanBing Zou
XianMing Kong
Renji Hospital · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStorage of leftover biosamples generates rich biobanks for future studies, saving time and money and limiting physical impact to sample donors.

objectiveTo investigate the attitudes of Chinese patients and the general public on providing consent for storage and use of leftover biosamples. DESIGN, SETTING AND

participantsCross-sectional surveys were conducted among randomly selected patients admitted to a Shanghai city hospital (n = 648) and members of the general public (n = 492) from May 2010 to July 2010.

main outcome measuresFace-to-face interviews collected respondents-report of their willingness to donate residual biosample, trust in medical institutions, motivation for donation, concerns of donated sample use, expectations for research results return, and so on.

resultsThe response rate was 83.0%. Of the respondents, 89.1% stated that they completely understood or understood most of questions. Willingness to donate residual sample was stated by 64.7%, of which 16.7% desired the option to withdraw their donations anytime afterwards. Only 42.3% of respondents stated they "trust" or "strongly trust" medical institutions, the attitude of trusting or strongly trusting medical institutions were significantly associated with willingness to donate in the general public group.(p<0.05) The overall assent rate for future research without specific consents was also low (12.1%). Hepatitis B virus carriers were significantly less willing than non-carriers to donate biosamples (32.1% vs. 64.7%, p<0.001).

conclusionsLow levels of public trust in medical institutions become serious obstacle for biosample donation and biobanking in China. Efforts to increase public understanding of human medical research and biosample usage and trust in the ethical purposes of biobanking are urgently needed. These efforts will be greatly advanced by the impending legislation on biobanking procedures and intent, and our results may help guide the structure of such law.

Indexed as

Public OpinionAdolescentAdultAgedAged, 80 and overAsian PeopleBiomedical ResearchChinaChi-Square DistributionComprehensionHealth Care SurveysHealth Knowledge, Attitudes, PracticeHumansInformed ConsentLogistic ModelsMiddle Aged

Identifiers

PMID22558323
PMCPMC3338618
OpenAlexW2023294558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.